Peregrine Pharmaceuticals | 销售和管理费用



Selling And Administration Expenses 更改 日
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Celldex Therapeutics USD 10.82M 557K 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
MannKind USD 25.01M 1.04M 2025-03
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Repligen USD 71.26M 10.93M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Xencor USD 17.34M 2.42M 2025-03



Peregrine Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jul 2025.